Haemonetics Corp/ US4050241003 /
| 2024-10-09 10:10:00 PM | Chg. -0.57 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 76.11USD | -0.74% | 369,658 Turnover: 19.11 mill. |
75.71Bid Size: 100 | 76.11Ask Size: 500 | 3.9 bill.USD | - | 32.81 |
Fundamentals
| FY 2024 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.32 USD | 2.20% |
| EPS Diluted: | 2.29 USD | 2.23% |
| Revenues per Share: | 25.75 USD | 11.35% |
| Book Value per Share: | 18.88 USD | 16.66% |
| Cash Flow per Share: | 3.57 USD | -33.83% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 1,309.06 USD | 12.01% |
| Net Income: | 117.56 USD | 1.87% |
| Operating Cash Flow: | 181.75 USD | - |
| Cash and Cash Equivalents: | 178.80 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 32.81 | 36.79 |
| P/S Ratio: | 2.96 | 3.31 |
| P/BV ratio: | 4.03 | 4.52 |
| P/CF Ratio: | 21.29 | 23.88 |
| PEG: | 14.89 | 16.70 |
| Earnings Yield: | 3.05% | 2.72% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 3.9 bill. USD | 4.34 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 51.18 mill. | |
Profitability
| Gross Profit Margin: | 52.83% |
| EBIT Margin: | 12.60% |
| Net Profit Margin: | 8.98% |
| Return on Equity: | 12.25% |
| Return on Assets: | 5.35% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.60% |
| Liquidity II / Quick Ratio: | 1.28% |
| Liquidity III / Current Ratio: | 2.56% |
| Debt / Equity Ratio: | 0.84% |
| Dynam. Debt / Equity Ratio: | 679.85% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2024-03-30 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
